Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Jun;39(6):659–666. doi: 10.1038/bjc.1979.117

Spontaneous development of cytotoxic activity in cultured lymphnode cells from tumour-bearing rats.

R A Robins, R C Rees, C G Brooks, R W Baldwin
PMCID: PMC2009986  PMID: 109111

Abstract

Incubation in vitro of lymphnode cells (LNC) from rats bearing a transplanted syngeneic methylcholanthrene-induced sarcoma (Mc7) resulted in the generation of a potent cytotoxic activity. Four to seven days' culture was required for development of cytotoxic activity, which was shown to be mediated by a heat-stable soluble factor. The cytotoxicity was not detectable in a 3 h or 15 h 51Cr-release assay, but was demonstrated in a 48 h microcytotoxicity assay, where post-labeling with isotopically labelled cell precursors was used to quantitate cell survival. The cytotoxicity of the cultured tumour-bearer LNC and their supernatant factor was shown to be cross-reactive for tumour cell lines other than sarcoma Mc7, and was also expressed against adult or embryonic fibroblasts.

Full text

PDF
659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Barker C. R. Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata. Br J Cancer. 1967 Dec;21(4):793–800. doi: 10.1038/bjc.1967.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blasecki J. W., Tevethia S. S. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice. Int J Cancer. 1975 Aug 15;16(2):275–283. doi: 10.1002/ijc.2910160210. [DOI] [PubMed] [Google Scholar]
  3. Brooks C. G., Rees R. C., Baldwin R. W. Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium. Int J Cancer. 1976 Dec 15;18(6):778–786. doi: 10.1002/ijc.2910180609. [DOI] [PubMed] [Google Scholar]
  4. Brooks C. G., Rees R. C., Robins R. A. Studies on the microcytotoxicity test. II. The uptake of amino acids ([3H]leucine or [75Se]methionine) but not nucleosides ([3H]thymidine or [125I]IUdR) or 51CrO24-provides a direct and quantitative measure of target cell survival in the presence of lymphoid cells. J Immunol Methods. 1978;21(1-2):111–124. doi: 10.1016/0022-1759(78)90228-4. [DOI] [PubMed] [Google Scholar]
  5. Burton R. C., Chism S. E., Warner N. L. In vitro induction of tumor specific immunity. VII. Does autosensitization occur with in vitro culture of T lymphocytes? J Immunol. 1977 Oct;119(4):1329–1339. [PubMed] [Google Scholar]
  6. Callewaert D. M., Lightbody J. J., Kaplan J., Jaroszewski J., Peterson W. D., Jr, Rosenberg J. C. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture. J Immunol. 1978 Jul;121(1):81–85. [PubMed] [Google Scholar]
  7. Chism S. E., Burton R. C., Warner N. L. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. J Natl Cancer Inst. 1976 Aug;57(2):377–387. doi: 10.1093/jnci/57.2.377. [DOI] [PubMed] [Google Scholar]
  8. Gorczynski R. M., Tigelaar R. E. Cell-mediated immunity to Murine tumor allografts. Increase in the activities of activated thymus-derived cells following in vitro incubation. Cell Immunol. 1975 Jul;18(1):121–143. doi: 10.1016/0008-8749(75)90042-8. [DOI] [PubMed] [Google Scholar]
  9. Gordon R. D., Simpson E., Samelson L. E. In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J Exp Med. 1975 Nov 1;142(5):1108–1120. doi: 10.1084/jem.142.5.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  11. Herberman R. B., Nunn M. E., Holden H. T., Staal S., Djeu J. Y. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer. 1977 Apr 15;19(4):555–564. doi: 10.1002/ijc.2910190417. [DOI] [PubMed] [Google Scholar]
  12. Kall M. A., Hellström I. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens. J Immunol. 1975 Mar;114(3):1083–1088. [PubMed] [Google Scholar]
  13. Karpas A. A humoral cytotoxic substance produced by a human killer cell line. Br J Cancer. 1977 Oct;36(4):437–445. doi: 10.1038/bjc.1977.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kuperman O., Fortner G. W., Lucas Z. J. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity. J Immunol. 1975 Nov;115(5):1282–1287. [PubMed] [Google Scholar]
  15. Laux D., Lausch R. N. Reversal of tumor-mediated suppression of immune reactivity by in vitro incubation of spleen cells. J Immunol. 1974 May;112(5):1900–1908. [PubMed] [Google Scholar]
  16. Muchmore A. V., Decker J. M., Blaese R. M. Spontaneous cytotoxicity of human peripheral blood mononuclear cells toward red blood cell targets. II. Time-dependent loss of suppressor cell activity. J Immunol. 1977 Nov;119(5):1686–1689. [PubMed] [Google Scholar]
  17. Muchmore A. V., Decker J. M., Blaese R. M. Spontaneous cytotoxicity of human peripheral mononuclear cells toward red blood cell targets in vitro. I. characterization of the killer cell. J Immunol. 1977 Nov;119(5):1680–1685. [PubMed] [Google Scholar]
  18. Oehler J. R., Lindsay L. R., Nunn M. E., Holden H. T., Herberman R. B. Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity. Int J Cancer. 1978 Feb 15;21(2):210–220. doi: 10.1002/ijc.2910210213. [DOI] [PubMed] [Google Scholar]
  19. Ortaldo J. R., Bonnard G. D., Herberman R. B. Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol. 1977 Oct;119(4):1351–1357. [PubMed] [Google Scholar]
  20. Ortiz de Landazuri M., Herberman R. B. In vitro activation of cellular immune response to Gross virus-induced lymphoma. J Exp Med. 1972 Nov 1;136(5):969–983. doi: 10.1084/jem.136.5.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pross H. F., Baines M. G. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease. Int J Cancer. 1976 Nov 15;18(5):593–604. doi: 10.1002/ijc.2910180508. [DOI] [PubMed] [Google Scholar]
  22. Shellam G. R., Knight R. A., Mitchison N. A., Gorczynski R. M., Maoz A. The specificity of effector T cells activated by tumours induced by murine oncornaviruses. Transplant Rev. 1976;29:249–276. doi: 10.1111/j.1600-065x.1976.tb00204.x. [DOI] [PubMed] [Google Scholar]
  23. Shustik C., Cohen I. R., Schwartz R. S., Latham-Griffin E., Waksal S. D. T lymphocytes with promiscuous cytotoxicity. Nature. 1976 Oct 21;263(5579):699–701. doi: 10.1038/263699a0. [DOI] [PubMed] [Google Scholar]
  24. Simpson E., Gordon R., Taylor M., Mertin J., Chandler P. Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity. Eur J Immunol. 1976 Jul;5(7):451–455. doi: 10.1002/eji.1830050705. [DOI] [PubMed] [Google Scholar]
  25. Vasudevan D. M., Brunner K. T., Cerottini J. C. Detection of cytotoxic T lymphocytes in the EL4 mouse leukemia system: increased activity of immune spleen and peritoneal cells following preincubation and cell fractionation procedures. Int J Cancer. 1974 Sep 15;14(3):301–313. doi: 10.1002/ijc.2910140303. [DOI] [PubMed] [Google Scholar]
  26. Wagner H., Harris A. W., Feldmann M. Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes. Cell Immunol. 1972 May;4(1):39–50. doi: 10.1016/0008-8749(72)90004-4. [DOI] [PubMed] [Google Scholar]
  27. Wright P. W., Ortiz de Landazuri M., Herberman R. B. Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity. J Natl Cancer Inst. 1973 Apr;50(4):947–954. doi: 10.1093/jnci/50.4.947. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES